m+Medelevator.RU
← Поиск публикаций
Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025

Small RNA sequencing of formalin-fixed paraffin embedded human skin biopsies reveals miRNA signatures for actinic keratosis and squamous cell carcinoma.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Pazdrowski Pawel, Seavey Corey E, Wieloch Aleksandra, Menon Vinal, Schneider Augusto, Noureddine Sarah A, Golusinski Pawel, Bowszyc-Dmochowska Monika, Polanska Adriana, Danczak-Pazdrowska Aleksandra, Masternak Michal M, Ashiqueali Sarah A

Аннотация

BACKGROUND: Histopathological characterization is a common method employed to identify actinic keratosis and squamous cell carcinoma. Oftentimes, formalin-fixed paraffin-embedded (FFPE) skin biopsies are accessible in repositories for retrospective analysis.

MATERIALS AND METHODS: In this study, we extracted total ribonucleic acid (RNA) from FFPE specimens, successfully conducted small RNA sequencing and performed differential expression analysis to assess candidate biomolecular signatures that are unique and similar between different skin lesions and their malignant transformations.

RESULTS AND CONCLUSIONS: Although RNA sequencing of FFPE specimens is challenging and requires further optimization, we identified several candidate microRNAs (miRNAs) across all 3 stages of keratinocytic intraepidermal neoplasia, including the upregulation of hsa-miR-145-5p, hsa-miR-30-5p, and hsa-miR-205-5p and downregulation of hsa-miR-486-5p against healthy controls. These miRNAs may serve as a potential diagnostic, prognostic, and therapeutic biomarkers for skin cancer. Future studies are needed to improve methods for FFPE analysis and to validate the key differences in miRNA signatures involved in skin cancer development.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты